Flow Pharma logo

Flow Pharma

East Palo Alto, CA

Flow Pharma offers a T-Cell based vaccine delivery platform. The vaccine platform has been tested in an HIV vaccine application (Immunity Project program in partnership with Until There’s A Cure) yielding promising results in animals and in human blood. Flow Pharma is now using a similar approach to develop a vaccine for Ebola, Marburg, and triple negative breast cancer. The company received the first breast cancer collaboration agreement at the largest cancer hospital in Saudi Arabia on 5/11/23. Flow Pharma has 10 issued patents in the US, EU, Canada and Australia and 10 published scientific articles can be found here www.flowpharma.com We are based in Cleveland, Ohio and Riyadh, Saudi Arabia.

flowpharma.com

Company Details

Founded

1999

Employees

Between 5 - 20 employees

Raised

$25,554,710

Headquarters Location

East Palo Alto, CA

Public

No

Acquired

No

CEO

Reid RubsamenReid Rubsamen

Founders

Reid Rubsamen
Reid Rubsamen

Company Collections

These are collections Flow Pharma is a part of. Click on the collection name to view similar companies.

Flow Pharma's Tech Stack